Orphan Drugs make all the difference to patients
World Courier
Headlines > Bio Developments
Improved transposons could cut cell therapy production costs says EMBL
06-Apr-2016 - EMBL researchers have developed variants of the “sleeping beauty” transposon they claim are more effective at inserting genetic material into cells.
US FDA approves Celltrion's Remicade biosimilar
06-Apr-2016 - The FDA has approved its first biosimilar mAb, Remsima – a Remicade biosimilar from Celltrion.
CrownBio develops mouse strains with human PD-1 for mAb testing
05-Apr-2016 - Crown Bioscience has developed humanized mouse cancer models which it claims provide biologic drug developers with an improved means of assessing efficacy.
SGS and DiscoverX to supply bioassays for biosimilar development
04-Apr-2016 - SGS has teamed with DiscoverX to offer bioassays for assessing the potency of prospective biosimilars of Roche’s Avastin and BMS’s Erbitux.
Eurofins agrees to buy US analytical services firm Advantar Laboratories
01-Apr-2016 - Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.
Research shows neural stem cells strike a spinal cord in rat models
29-Mar-2016 - Researchers at the University of California have successfully regenerated corticospinal tract tissue in rat models using stem cell-derived neurons.
Plasticell and Sphere team to make cell therapies cheaper
29-Mar-2016 - Plasticell has teamed up with encapsulation and screening tech firm Sphere Fluidics to develop genetic modification technology for cell therapy production.
Quanterix raises $46m with goal of adding 60 new assays
23-Mar-2016 - The funding will be used to accelerate the company’s global expansion of its proprietary digital immunoassay platform into new markets.
BioOutsource announces new assays for three biologics
23-Mar-2016 - Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industry, has announced new, ready-to-use assays for testing biosimilars.
Meringue? No, you're not wrong: TxCell outlines unusual Ovasave delivery method
22-Mar-2016 - TxCell is working on new ways of delivering its Crohn's disease therapy Ovasave that will replace the somewhat unusual method it is using in clinical trials.
CSL Behring using Albumedix tech to extend the half-life of new haemophilia drug
21-Mar-2016 - CSL Behring has opted to extend the half-life of its haemophilia B treatment Idelvion using a technology developed by Novozymes A/S subsidiary Albumedix.
UK CRO BioPharmaSpec eyes growth in India and Asia-Pacific
21-Mar-2016 - BioPharmaSpec has set up business development teams for the Indian and Asia-Pacific markets and predicted increased demand for biosimilar characterisation services.
Gyros and Protein Tech to merge, creating end-to-end biopeptide tools firm
16-Mar-2016 - The combination of Gyros and Protein Technologies will give biomanufacturers greater access to protein and peptide processing tools and reagents, the CEO says.
Sanofi aiming to 'cut years off' vaccine development timelines for Zika says R&D head
15-Mar-2016 - Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
CAR T Cell firm Autolus raises £40m in Series B funding
15-Mar-2016 - UK-based drug developer Autolus has secured £40m ($57m) to develop its pipeline and license more T-cell engineering technologies from UCL.
Life science becoming ‘growth engine’ following Sigma-Aldrich buy, Merck
10-Mar-2016 - Germany’s Merck expects to achieve cost synergies of €90m ($98m) in 2016 from the integration of Sigma-Aldrich which the firm acquired in November.
TxCell to continue improving Ovasave production network post-suspension
09-Mar-2016 - New facilities and a successful CMO tech transfer have helped turnaround the manufacturing of cell therapy product Ovasave, says TxCell after production was suspended last year.
Ginkgo Bioworks: mini-bioreactor will speed expansion into pharma
08-Mar-2016 - Industrial microorganism design firm Ginkgo Bioworks expects to cut six months off development timelines using mini-bioreactor technology supplied by Sartorius Stedim Biotech (SSB).
First Chinese-manufactured biologic dosed in an EU clinical trial
03-Mar-2016 - WuXi Biologics and Prima BioMed have announced that the first dose of a Chinese-manufactured biologic has been dosed in a clinical trial in the European Union.
Medpace to run Ph III trial of blood cancer ADC for Actinium
03-Mar-2016 - Medpace will run a Phase III trial of candidate blood cancer treatment Iomab-B under a new contract with developer Actinium Pharmaceuticals.
BioOutsource facility passes US FDA inspection
02-Mar-2016 - A laboratory operated by recent Sartorius Stedim Biotech (SSB) acquisition BioOutsoruce has passed a GMP inspection by the US FDA.
Tarantula toxin may yield non-opioid treatments for chronic pain
01-Mar-2016 - A tarantula venom toxin that inhibits a novel pain receptor will guide development of more effective non-opioid painkillers say researchers in Australia.
Sanofi teams with University of Tokyo for drug discovery
29-Feb-2016 - Sanofi will tap Japanese academics' personalised medicine knowhow under a new collaboration with the University of Tokyo's translational research initiative (TR).
T Cell therapies 'Heat' up as biotech looks to third public offering
24-Feb-2016 - Heat Biologics hopes to raise an additional $14m (€13m) to support its T Cell therapy pipeline made using its allogeneic production platforms.
Unchained Labs continues breaking into biologics market
24-Feb-2016 - Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.
Most Popular News
Key Industry Events
|
Our events, Shows & Conferences... |
Products
Bioreactor based engineering of large-scale cartilage grafts for joint resurfacing
Applikon Biotechnology
Applikon Biotechnology
